A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Clinical trial NCT00727987 · COMPLETED
Trial details
- NCT number
- NCT00727987
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.